References
- Putaala J. Ischemic stroke in young adults. Continuum (Minneap Minn). 2020; 26:386–414.
- Couture P, Chazal T, Rosso C, Haroche J, Léger A, Hervier B, et al. Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study. J Neurol. 2018; 265:757–63.
- Adams RJ. Stroke prevention and treatment in sickle cell disease. Arch Neurol. 2001; 58:565–8.
- Trömmer K, Kostev K, Jacob L, Tanislav C. Increased incidence of stroke and transient ischemic attack in patients with rheumatoid arthritis and ankylosing spondylitis in Germany. Neuroepidemiology. 2021; 55:162–70.
- Roman-Filip C, Catană MG, Mihăilă RG. Prognostic markers for ischemic stroke - are they truly reliable? Med Pharm Rep. 2023; 96:65–70.
- Sharma D, Bhaskar SMM. Prognostic Role of the platelet-lymphocyte ratio in acute ischemic stroke patients undergoing reperfusion therapy: a meta-analysis. J Cent Nerv Syst Dis. 2022; 14. doi: 10.1177/11795735221110373
- Yan YK, Huang H, Li DP, Ai ZY, Li X, Sun Z. Prognostic value of the platelet-to-lymphocyte ratio for outcomes of stroke: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021; 25:6529–38.
- Wen H, Wang N, Lv M, Yang Y, Liu H. The early predictive value of platelet to lymphocyte ratio to hemorrhagic transformation of young acute ischemic stroke. Asian Biomed (Res Rev News). 2023; 17:267–272.